"Lipopolysaccharides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed)
| Descriptor ID |
D008070
|
| MeSH Number(s) |
D09.400.500 D09.698.718.450 D10.494 D23.050.161.616.525 D23.946.123.329.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharides".
Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharides".
This graph shows the total number of publications written about "Lipopolysaccharides" by people in this website by year, and whether "Lipopolysaccharides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 2 | 4 |
| 1999 | 1 | 4 | 5 |
| 2000 | 2 | 3 | 5 |
| 2001 | 0 | 5 | 5 |
| 2002 | 2 | 9 | 11 |
| 2003 | 4 | 1 | 5 |
| 2004 | 0 | 1 | 1 |
| 2005 | 4 | 6 | 10 |
| 2006 | 3 | 9 | 12 |
| 2007 | 0 | 11 | 11 |
| 2008 | 5 | 5 | 10 |
| 2009 | 3 | 9 | 12 |
| 2010 | 0 | 4 | 4 |
| 2011 | 3 | 7 | 10 |
| 2012 | 1 | 7 | 8 |
| 2013 | 0 | 7 | 7 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 5 | 6 |
| 2016 | 4 | 8 | 12 |
| 2017 | 1 | 5 | 6 |
| 2018 | 4 | 4 | 8 |
| 2019 | 2 | 5 | 7 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 7 | 7 |
| 2023 | 2 | 5 | 7 |
| 2024 | 5 | 3 | 8 |
| 2025 | 4 | 4 | 8 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipopolysaccharides" by people in Profiles.
-
Fibrinogen and lipopolysaccharide promote TLR4-dependent glucocorticoid resistance in airway mycosis-driven allergic airway disease. Mucosal Immunol. 2026 Aug; 19(4):100354.
-
Exogenous arginine differentially regulates inflammatory cytokine and inducible nitric oxide synthase expression in macrophages. Immunohorizons. 2025 07 14; 9(8).
-
Performance of stool Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis among adults living with HIV: a multicentre, prospective diagnostic study. Lancet Microbe. 2025 07; 6(7):101085.
-
A novel method for detecting Lipoarabinomannan in urine with the promise of meeting the WHO target product profile for the diagnosis of tuberculosis. Tuberculosis (Edinb). 2025 May; 152:102619.
-
TCA metabolism regulates DNA hypermethylation in LPS and Mycobacterium tuberculosis-induced immune tolerance. Proc Natl Acad Sci U S A. 2024 10 08; 121(41):e2404841121.
-
Citrulline and ADI-PEG20 reduce inflammation in a juvenile porcine model of acute endotoxemia. Front Immunol. 2024; 15:1400574.
-
Blocking IL-17a Signaling Decreases Lung Inflammation and Improves Alveolarization in Experimental Bronchopulmonary Dysplasia. Am J Pathol. 2024 11; 194(11):2023-2035.
-
Therapeutic effect of Echinococcus granulosus cyst fluid on bacterial sepsis in mice. Parasit Vectors. 2023 Dec 08; 16(1):450.
-
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality. Am J Physiol Gastrointest Liver Physiol. 2023 11 01; 325(5):G471-G491.
-
Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia. Int J Mol Sci. 2023 Jul 22; 24(14).